T2DM constitutes up to 90% of all diabetes and it is characterized by chronic hyperglycaemia resulting from defects in insulin secretion and/or insulin action and metabolic disorders of protein and lipids [7, 8]. This evidence concerns the gene INS and metabolic disease.